mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.05 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.05 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.05 |
mRNA |
SGX-523 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.05 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
0.14 |
0.05 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.06 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.06 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.06 |
mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
-0.096 |
0.06 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.06 |